Barrau, Víctor http://orcid.org/0000-0003-2252-668X
López-Romero, Laura http://orcid.org/0000-0003-0513-6698
Bosch, Rosa http://orcid.org/0000-0002-7596-183X
Torrubia, Rafael http://orcid.org/0000-0002-6826-6572
Casas, Miquel http://orcid.org/0000-0003-3496-8522
Molinuevo, Beatriz http://orcid.org/0000-0003-0263-4077
Funding for this research was provided by:
Conselleria d'Educació, Investigació, Cultura i Esport (Programa de Axudas á Etapa Posdoutoral 2017)
“la Caixa” Foundation (la Caixa “Banking Foundation”)
Diputació de Barcelona
Diputació de Lleida (Diputació de Lleida)
Departament de Salut, Generalitat de Catalunya (Departament de Salut, Generalitat de Catalunya)
Article History
Accepted: 22 July 2021
First Online: 19 August 2021
Declarations
:
: The funding sources had no role in the study design, collection, analysis or interpretation of data, the writing of the article or decision to submit the article for publication. Miguel Casas has received fees to give talks for Janssen- Cilag, Ferrer-Brainfarma, Pfizer, Lundbeck, Otsuka, Lilly, Shire, Rovi and Adamed. He has received financial compensation for his participation as a member of the Janssen- Cilag, Lilly, Shire, Lundbeck, Otsuka, Ferrer and Rovi board. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.